We are live on ! Find out more
MRKR icon

Marker Therapeutics
MRKR

30 hedge funds and large institutions have $1.41M invested in Marker Therapeutics in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 9

20.16% more ownership

Funds ownership: 2.34% → 22.5% (+20%)

36% less funds holding

Funds holding: 47 → 30 (-17)

73% less capital invested

Capital invested by funds: $5.24M → $1.41M (-$3.83M)

89% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 18

Holders
30
Holders Change
-17
Holders Change %
-36.17%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
11
Reduced
9
Closed
18
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AAM
AR Asset Management
California
+$96.8K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$41.9K
3
Millennium Management
Millennium Management
New York
+$32.9K
4
UBS Group
UBS Group
Switzerland
+$12.4K
5
Bank of America
Bank of America
North Carolina
+$9.89K

Top Sellers

Rank Fund Capital Flow
1
IA
IFP Advisors
Florida
-$30K
2
MLIC
Mandatum Life Insurance Company
Finland
-$26K
3
BlackRock
BlackRock
New York
-$25.8K
4
RJA
Raymond James & Associates
Florida
-$25K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$23.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
HNB
26
Huntington National Bank
Ohio
$50 – – –
VCM
27
Versant Capital Management
Arizona
$11 – – –
TWA
28
TCI Wealth Advisors
Arizona
$8 – – –
MLIC
29
Mandatum Life Insurance Company
Finland
– -$26K -9,900 Closed
RJA
30
Raymond James & Associates
Florida
– -$25K -9,400 Closed
NRS
31
Neville Rodie & Shaw
New York
– -$16K -6,020 Closed
WA
32
WealthTrust Axiom
Pennsylvania
– -$6.04K -2,270 Closed
HighTower Advisors
33
HighTower Advisors
Illinois
– -$6K -2,208 Closed
Acadian Asset Management
34
Acadian Asset Management
Massachusetts
– -$5K -2,186 Closed
TSS
35
Two Sigma Securities
New York
– -$4.98K -1,873 Closed
Two Sigma Investments
36
Two Sigma Investments
New York
– -$4.23K -1,590 Closed
Bank of New York Mellon
37
Bank of New York Mellon
New York
– -$4.19K -1,576 Closed
Commonwealth Equity Services
38
Commonwealth Equity Services
Massachusetts
– -$3K -1,240 Closed
Jane Street
39
Jane Street
New York
– -$3.29K -1,237 Closed
CFS
40
CRA Financial Services
New Jersey
– -$3.06K -1,150 Closed
AWP
41
Ascent Wealth Partners
New York
– -$2.73K -1,027 Closed
GSIAS
42
Garden State Investment Advisory Services
New Jersey
– -$2.66K -1,000 Closed
IA
43
IFP Advisors
Florida
– -$30K -350 Closed
SPIA
44
Steward Partners Investment Advisory
New York
– -$249 -94 Closed
BNP Paribas Financial Markets
45
BNP Paribas Financial Markets
France
– -$64 -24 Closed
JP Morgan Chase
46
JP Morgan Chase
New York
– -$2 -1 -0.8%
Royal Bank of Canada
47
Royal Bank of Canada
Ontario, Canada
– +$24 +10 +48%
1
2

MRKR Hedge Fund Activity: Q1 2023 in Review

30 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Marker Therapeutics (MRKR) for Q1 2023, worth a combined $1.41M — down 73% from $5.24M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of MRKR and 2 opened new positions — a net loss of 16 holders — while 9 trimmed existing stakes and 11 added.

The largest buyer was AR Asset Management, opening a new position worth an estimated $96.8K. The largest seller was IFP Advisors, exiting entirely with an estimated $30K sold.

  • 30 institutional investors held Marker Therapeutics (MRKR) as of Q1 2023, down from 47 in Q4 2022.
  • Funds reported $1.41M of Marker Therapeutics stock for Q1 2023, down 73% quarter-over-quarter.
  • 2 funds opened new Marker Therapeutics positions in Q1 2023 and 18 closed out, a net change of -16 holders.
  • The largest Marker Therapeutics buyer in Q1 2023 was AR Asset Management, an estimated $96.8K added.
  • The largest Marker Therapeutics seller in Q1 2023 was IFP Advisors, an estimated $30K sold.

Based on aggregated 13F filings for Q1 2023.